# Nephrocare Health Services Limited (NEPHROPLUS)

> NEPHROPLUS closed at ₹609.90 on 30 Oct 2026, market cap ₹6,120 cr, latest results for the quarter ended 30 Jun 2026. Revenue, profit, ROE, debt, own P/E range and sector-peer comparison from the SEBI filing.

Nephrocare Health Services Limited (NSE: NEPHROPLUS) closed at ₹609.90 on 30 Oct 2026, against a 52-week range of ₹446.00 – ₹781.50.

In the quarter ended 30 Jun 2026 (consolidated, filed 11 Aug 2026) it reported revenue of ₹282 cr and net profit of ₹32 cr, a 11.4% net margin.

No trailing P/E is published: only 3 filed quarters available — a trailing twelve months needs 4.

From the balance sheet dated 31 Mar 2026: return on equity 11.5%, ROCE 16.0%, debt-to-equity 0.07.

Against 65 Healthcare peers on NSE: Net margin higher than 33% of 63 sector peers; PBT margin higher than 36% of 63 sector peers; ROE higher than 33% of 63 sector peers.

## Key figures

| Figure | Value |
|---|---|
| Last close | ₹609.90 (30 Oct 2026) |
| Change 1 month / 6 months / 1 year | -14.0% / +14.3% / — |
| 52-week low – high | ₹446.00 – ₹781.50 |
| Market capitalisation | ₹6,120 cr |
| Quarter revenue | ₹282 cr |
| Quarter net profit | ₹32 cr |
| Net margin | 11.4% |
| Return on equity | 11.5% |
| ROCE | 16.0% |
| Debt / equity | 0.07 |
| Current ratio | 2.80 |
| Free cash flow | ₹114 cr |
| Average daily turnover (50 days) | ₹12.4 cr |

## Questions

### What were Nephrocare Health Services Limited's latest quarterly results?

For the quarter ended 30 Jun 2026, Nephrocare Health Services Limited reported revenue of ₹282 cr and net profit of ₹32 cr (consolidated), filed with the exchange on 11 Aug 2026.

### What is Nephrocare Health Services Limited's ROE?

Return on equity is 11.5% based on the balance sheet dated 31 Mar 2026.

### Does Nephrocare Health Services Limited have debt?

Debt-to-equity is 0.07 on the balance sheet dated 31 Mar 2026.

### What is NEPHROPLUS's 52-week high and low?

Over the last 52 weeks to 30 Oct 2026, NEPHROPLUS traded between ₹446.00 and ₹781.50.

Sector: [Healthcare](https://trinetra.trade/sectors/healthcare) · Page: https://trinetra.trade/fundamentals/NEPHROPLUS

_TRINETRA is a research and education tool. Nothing on this site is investment advice or a recommendation to buy or sell any security. Markets carry risk; do your own research and consult a SEBI-registered adviser before investing._